S, S., JA, P., EA, L., J, F., JK, P., TA, G., & D, B. (2017). Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy. Dove Medical Press.
Style de citation Chicago (17e éd.)S, Sunkaraneni, Passarell JA, Ludwig EA, Fiedler-Kelly J, Pitner JK, Grinnell TA, et Blum D. Prediction of Efficacy for Conversion from Adjunctive Therapy to Monotherapy with Eslicarbazepine Acetate 800 Mg Once Daily for Partial-onset Epilepsy. Dove Medical Press, 2017.
Style de citation MLA (8e éd.)S, Sunkaraneni, et al. Prediction of Efficacy for Conversion from Adjunctive Therapy to Monotherapy with Eslicarbazepine Acetate 800 Mg Once Daily for Partial-onset Epilepsy. Dove Medical Press, 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.